These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30950176)

  • 1. Time for a makeover-cosmetics regulation in the United States.
    Cornell EM; Janetos TM; Xu S
    J Cosmet Dermatol; 2019 Dec; 18(6):2041-2047. PubMed ID: 30950176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act.
    Nguyen HP; Bergfeld WF; Forman HP; Belsito DV; Bolognia JL
    J Am Acad Dermatol; 2018 Aug; 79(2):403-405. PubMed ID: 29625132
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of Cosmetics in the United States.
    Katz LM; Lewis KM; Spence S; Sadrieh N
    Dermatol Clin; 2022 Jul; 40(3):307-318. PubMed ID: 35750414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants.
    Cornell E; Kwa M; Paller AS; Xu S
    Pediatr Dermatol; 2018 Mar; 35(2):225-229. PubMed ID: 29575075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalls of foods and cosmetics due to microbial contamination reported to the U.S. Food and Drug Administration.
    Wong S; Street D; Delgado SI; Klontz KC
    J Food Prot; 2000 Aug; 63(8):1113-6. PubMed ID: 10945589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it a cosmetic, a drug, or both? (Or is it soap?).
    Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration
    Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
    Jenson D; Lester J; Berman ML
    Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety assessment process--setting the scene: an FDA perspective.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S5-10. PubMed ID: 12388844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosmetic Regulations: A Comparative Study.
    Suhag J; Dureja H
    Skinmed; 2015; 13(3):191-4. PubMed ID: 26380505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of ingredients used in cosmetics.
    Bergfeld WF; Belsito DV; Marks JG; Andersen FA
    J Am Acad Dermatol; 2005 Jan; 52(1):125-32. PubMed ID: 15627090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administrative Destruction of Certain Drugs Refused Admission to the United States. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Sep; 80(178):55237-42. PubMed ID: 26387150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not in my makeup: the need for enhanced premarket regulatory authority over cosmetics in light of increased usage of engineered nanoparticles.
    Johnson DR
    J Contemp Health Law Policy; 2009; 26(1):82-124. PubMed ID: 20112620
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of high-risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016.
    Janetos TM; Akintilo L; Xu S
    J Cosmet Dermatol; 2019 Oct; 18(5):1361-1365. PubMed ID: 30565865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globalization of cosmetic regulations.
    Blaschke JW
    Food Drug Law J; 2005; 60(3):413-9. PubMed ID: 16304748
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics.
    Becker LC; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):16S-33S. PubMed ID: 27913785
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.